Description
A noninvasive MRI scan that accurately assesses signs of liver disease, offering a complete picture of liver health through quantitative multiparametric MRI technology
Market positioning
Leading noninvasive liver assessment technology, positioned as the gold standard alternative to liver biopsy for MASLD/MASH diagnosis and monitoring
Target audience
Healthcare providers, clinicians, and patients with suspected or confirmed liver disease, particularly those with MASLD/MASH and chronic liver disease
Use cases
Noninvasive liver disease assessment, MASLD/MASH diagnosis and monitoring, treatment response tracking, cardiovascular risk assessment related to liver health
Company information
Company size
Small-Medium Enterprise (50-200 employees)
Revenue
$10-50 million annually
Scale
Global, primarily focused on healthcare markets in US, Europe, and Asia-Pacific
Number of users
Thousands of healthcare providers globally across 40+ countries
Features
Pricing
Rating
No Trustpilot link available
Pros and cons
Based on: (AI summary)
Pros
- Best in class accuracy for MASH detection and stratification
- Outperforms elastography with lower failure rates, especially in high BMI patients
- Strong correlation with biopsy features (NAS and fibrosis)
- Prognostic value for both liver and cardiovascular outcomes
- Cost-effective compared to biopsy and FibroScan
Cons
- Requires MRI access and expertise
- Higher upfront cost compared to basic blood tests
- Limited to facilities with compatible MRI equipment
- May have longer wait times due to MRI scheduling
Feature Comparison
Top features across 20 competitors (most common first)
| Feature | Continuous … | Lab-on-a-Pa… | LiverMultiS… | Digital Hea… | Apple Watch | Apple Watch… | Wearable Fi… | Continuous … | Fibion Heli… | Fibion Kron… | Fibion SENS… | Comprehensi… | Digital Hea… | Galaxy Watch | ActiGraph A… | Liver Healt… | Remote Pati… | SimpleSense… | Connected G… | Osin Loop |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Continuous glucose monitoring | ||||||||||||||||||||
| Mobile app integration | ||||||||||||||||||||
| Heart rate monitoring | ||||||||||||||||||||
| Health monitoring sensors | ||||||||||||||||||||
| Integration with healthcare systems | ||||||||||||||||||||
| Activity tracking | ||||||||||||||||||||
| Circadian rhythm tracking | ||||||||||||||||||||
| Data sharing capabilities | ||||||||||||||||||||
| Mobile app connectivity | ||||||||||||||||||||
| Real-time alerts | ||||||||||||||||||||
| Trend analysis | ||||||||||||||||||||
| Antibiotic dosing insights | ||||||||||||||||||||
| DNA-based biosensors | ||||||||||||||||||||
| Hundreds of biomarker monitoring | ||||||||||||||||||||
| Patch-based wearable | ||||||||||||||||||||
| Real-time diagnostics | ||||||||||||||||||||
| Sepsis monitoring | ||||||||||||||||||||
| 5-minute acquisition time | ||||||||||||||||||||
| Alternative to liver biopsy | ||||||||||||||||||||
| Automated DICOM data transfer |